Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

imax corp. - IMAX

IMAX

Close Chg Chg %
38.26 -0.07 -0.18%

Closed Market

38.19

-0.07 (0.18%)

Volume: 619.95K

Last Updated:

Mar 25, 2026, 3:59 PM EDT

Trade Now

Company Overview: imax corp. - IMAX

IMAX Key Data

Open

$38.49

 Day Range

37.75 - 38.81

52 Week Range

20.48 - 43.16

 Market Cap

$2.06B

Shares Outstanding

53.99M

 Public Float

43.54M

Beta

0.33

 Rev. Per Employee

N/A

P/E Ratio

60.85

 EPS

$0.65

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.17M

  

IMAX Performance

1 Week
 
 4.14%
 
1 Month
 
 -10.79%
 
3 Months
 
 1.43%
 
1 Year
 
 46.17%
 
5 Years
 
 93.27%
 

IMAX Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 12
Full Ratings ➔

About imax corp. - IMAX

IMAX Corp. is an entertainment technology company, which engages in the business of motion picture technologies and presentations. It operates through the Content Solutions and Technology Products and Services segments. The Content Solutions segment includes content enhancement and distribution services. The Technology Products and Services segment focuses on the sale, lease, and maintenance of IMAX Systems. The company was founded by Graeme Ferguson, Roman Kroitor, Robert P. Kerr and William Shaw in 1967 and is headquartered in Mississauga, Canada.

IMAX At a Glance

IMAX Corp.
2525 Speakman Drive
Mississauga, Ontario L5K 1B1
Phone 1-905-403-6500 Revenue 410.21M
Industry Electronics/Appliances Net Income 34.88M
Sector Consumer Durables 2025 Sales Growth 16.469%
Fiscal Year-end 12 / 2026 Employees 679
View SEC Filings

IMAX Valuation

P/E Current 60.854
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 58.863
Price to Sales Ratio 5.005
Price to Book Ratio 5.898
Price to Cash Flow Ratio 16.16
Enterprise Value to EBITDA 14.434
Enterprise Value to Sales 5.561
Total Debt to Enterprise Value 0.127

IMAX Efficiency

Revenue/Employee 604,141.384
Income Per Employee 51,363.77
Receivables Turnover 2.957
Total Asset Turnover 0.476

IMAX Liquidity

Current Ratio 1.67
Quick Ratio 1.509
Cash Ratio 0.748

IMAX Profitability

Gross Margin 57.915
Operating Margin 23.306
Pretax Margin 15.429
Net Margin 8.502
Return on Assets 4.045
Return on Equity 10.944
Return on Total Capital 5.557
Return on Invested Capital 6.184

IMAX Capital Structure

Total Debt to Total Equity 85.731
Total Debt to Total Capital 46.159
Total Debt to Total Assets 32.401
Long-Term Debt to Equity 74.513
Long-Term Debt to Total Capital 40.119
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Imax Corp. - IMAX

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
300.81M 374.84M 352.21M 410.21M
Sales Growth
+18.02% +24.61% -6.04% +16.47%
Cost of Goods Sold (COGS) incl D&A
150.18M 166.08M 166.27M 172.64M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
56.66M 60.02M 65.50M 62.45M
Depreciation
31.92M 31.98M 31.52M 32.46M
Amortization of Intangibles
6.10M 5.95M 6.97M 8.81M
COGS Growth
+20.19% +10.59% +0.11% +3.83%
Gross Income
150.63M 208.76M 185.94M 237.57M
Gross Income Growth
+15.93% +38.60% -10.93% +27.77%
Gross Profit Margin
+50.07% +55.69% +52.79% +57.91%
2022 2023 2024 2025 5-year trend
SG&A Expense
146.19M 152.88M 133.12M 141.97M
Research & Development
3.40M 8.31M 3.20M 4.12M
Other SG&A
142.79M 144.57M 129.92M 137.85M
SGA Growth
+18.55% +4.58% -12.92% +6.64%
Other Operating Expense
- - - -
-
Unusual Expense
5.40M 3.43M 7.02M 26.21M
EBIT after Unusual Expense
(968.00K) 52.45M 45.80M 69.39M
Non Operating Income/Expense
(2.92M) 483.00K (14.00K) 1.26M
Non-Operating Interest Income
1.43M 2.49M 2.18M 2.80M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
5.88M 6.82M 8.08M 7.36M
Interest Expense Growth
-17.13% +16.06% +18.52% -8.93%
Gross Interest Expense
5.88M 6.82M 8.08M 7.36M
Interest Capitalized
- - - -
-
Pretax Income
(9.77M) 46.12M 37.70M 63.29M
Pretax Income Growth
-188.91% +572.07% -18.26% +67.89%
Pretax Margin
-3.25% +12.30% +10.70% +15.43%
Income Tax
10.11M 13.05M 5.00M 17.77M
Income Tax - Current - Domestic
1.15M 3.10M 1.35M 1.08M
Income Tax - Current - Foreign
11.03M 11.40M 9.28M 15.92M
Income Tax - Deferred - Domestic
(943.00K) (2.46M) 3.39M (1.23M)
Income Tax - Deferred - Foreign
(1.13M) 1.01M (9.02M) 2.00M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(19.88M) 33.07M 32.70M 45.53M
Minority Interest Expense
2.92M 7.73M 6.64M 10.65M
Net Income
(22.80M) 25.34M 26.06M 34.88M
Net Income Growth
-2.11% +211.12% +2.86% +33.83%
Net Margin Growth
-7.58% +6.76% +7.40% +8.50%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(22.80M) 25.34M 26.06M 34.88M
Preferred Dividends
- - - -
-
Net Income Available to Common
(22.80M) 25.34M 26.06M 34.88M
EPS (Basic)
-0.4023 0.4665 0.4949 0.6502
EPS (Basic) Growth
-6.54% +215.96% +6.09% +31.38%
Basic Shares Outstanding
56.67M 54.31M 52.65M 53.64M
EPS (Diluted)
-0.4023 0.4594 0.4838 0.6279
EPS (Diluted) Growth
-6.54% +214.19% +5.31% +29.79%
Diluted Shares Outstanding
56.67M 55.15M 53.86M 55.54M
EBITDA
61.09M 115.90M 118.32M 158.05M
EBITDA Growth
-2.55% +89.71% +2.09% +33.58%
EBITDA Margin
+20.31% +30.92% +33.59% +38.53%

Snapshot

Average Recommendation BUY Average Target Price 45.167
Number of Ratings 12 Current Quarters Estimate 0.211
FY Report Date 03 / 2026 Current Year's Estimate 1.689
Last Quarter’s Earnings 0.58 Median PE on CY Estimate N/A
Year Ago Earnings 1.45 Next Fiscal Year Estimate 1.963
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 10 10 10 10
Mean Estimate 0.21 0.37 1.69 1.96
High Estimates 0.28 0.57 2.07 2.38
Low Estimate 0.15 0.29 1.38 1.73
Coefficient of Variance 21.72 21.98 11.39 10.14

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 11 11 11
OVERWEIGHT 0 0 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Imax Corp. - IMAX

Date Name Shares Transaction Value
Mar 11, 2026 Mark Welton President IMAX Global Theatres 19,613 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 11, 2026 Mark Welton President IMAX Global Theatres 19,334 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 11, 2026 Mark Welton President IMAX Global Theatres 14,325 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 11, 2026 Mark Welton President IMAX Global Theatres N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 11, 2026 Mark Welton President IMAX Global Theatres 173,216 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $40.8 per share 7,067,212.80
Mar 11, 2026 Mark Welton President IMAX Global Theatres 205,155 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 11, 2026 Mark Welton President IMAX Global Theatres 186,309 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 11, 2026 Mark Welton President IMAX Global Theatres 145,492 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $40.8 per share 5,936,073.60
Mar 11, 2026 Mark Welton President IMAX Global Theatres 165,273 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 11, 2026 Mark Welton President IMAX Global Theatres 155,607 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 11, 2026 Mark Welton President IMAX Global Theatres 141,282 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 11, 2026 Anne Globe Chief Marketing Officer 18,574 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $40.8 per share 757,819.20
Mar 11, 2026 Anne Globe Chief Marketing Officer 19,978 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 11, 2026 Anne Globe Chief Marketing Officer 11,000 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 11, 2026 Robert Darin Lister Chief Legal & Sr Exec VP 172,380 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 11, 2026 Anne Globe Chief Marketing Officer 25,478 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 11, 2026 Robert Darin Lister Chief Legal & Sr Exec VP 186,705 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 11, 2026 Jose Zlatar SVP, Controller & PAO 2,028 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 11, 2026 Anne Globe Chief Marketing Officer 12,227 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 11, 2026 Anne Globe Chief Marketing Officer 12,512 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Imax Corp. in the News